Replies to post #244534 on Biotech Values

[dewophile]

The current stage of development though is comparable to an early stage bio that just completed a successful series B. They don’t even have a preclinical candidate in lead optimization

[TheFinalCD]

nltx news https://finance.yahoo.com/news/neoleukin-therapeutics-provides-strategic-announces-220000907.html